Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Ines Silva
Integrated Molecular and Immunophenotypic Analysis of NK Cells in Anti-Pd-1 Treated Metastatic Melanoma Patients
OncoImmunology
Oncology
Allergy
Immunology
Intestinal Microbiota Predict Response and Toxicities During Anti-Pd-1/Anti-Ctla-4 Immunotherapy
Pathology
Forensic Medicine
Pathology
Related publications
Comprehensive Molecular and Clinical Characterization of Asian Melanoma Patients Treated With Anti-Pd-1 Antibody
BMC Cancer
Cancer Research
Oncology
Genetics
777 Enhanced Recovery of PD-1 Expression on the Cell Surface of PD-1 Negative T Cells in Nivolumab-Treated Advanced Melanoma Patients
Journal of Investigative Dermatology
Biochemistry
Dermatology
Cell Biology
Molecular Biology
CTLA4 Methylation Predicts Response to Anti–PD-1 and Anti–CTLA-4 Immunotherapy in Melanoma Patients
JCI insight
Medicine
823 Biomarker Approaches for Anti-Pd-1 in Melanoma: A Meta-Analysis
Journal of Investigative Dermatology
Biochemistry
Dermatology
Cell Biology
Molecular Biology
Comment on ‘Efficacy and Toxicity of Treatment With the Anti-Ctla-4 Antibody Ipilimumab in Patients With Metastatic Melanoma After Prior Anti-Pd-1 Therapy’
British Journal of Cancer
Cancer Research
Oncology
Cutaneous Adverse Events (AEs) of Anti-Programmed Cell Death (PD)-1 Therapy in Patients With Metastatic Melanoma: A Single-Institution Cohort
Journal of the American Academy of Dermatology
Dermatology
Association Between Circulating Tumor DNA and Pseudoprogression in Patients With Metastatic Melanoma Treated With Anti–Programmed Cell Death 1 Antibodies
JAMA Oncology
Cancer Research
Oncology
Site‐specific Response Patterns, Pseudoprogression, and Acquired Resistance in Patients With Melanoma Treated With Ipilimumab Combined With Anti–PD‐1 Therapy
Cancer
Cancer Research
Oncology
Safety and Tumor Responses With Lambrolizumab (Anti–PD-1) in Melanoma
New England Journal of Medicine
Medicine
